Generate an empirically testable hypothesis

Hypothesis 1

Gut-derived butyrate mitigates obesity-induced neuroinflammation and depressive-like behaviors by epigenetically repressing the TLR4/NF-κB signaling axis in microglia through histone deacetylase (HDAC) inhibition.

Mechanistic rationale

• Obesity-associated gut dysbiosis leads to an increased Firmicutes-to-Bacteroidetes ratio and reduced levels of butyrate-producing bacteria like Faecalibacterium prausnitzii. (Derived, Medium; PMID: 41762381, PMID: 41774188)
• Decreased intestinal barrier integrity in obesity facilitates the systemic translocation of lipopolysaccharides (LPS), which cross the blood-brain barrier to activate microglia via the TLR4/NF-κB pathway. (Derived, Medium; PMID: 41859191, PMID: 41774188, PMID: 41823868)
• Butyrate acts as a potent inhibitor of histone deacetylases (HDACs), which can increase histone acetylation and modulate the expression of inflammatory genes. (Derived, Low; PMID: 24226773, PMID: 27231050, PMID: 41762317)
• The maturation and homeostasis of microglia in the central nervous system are regulated by host microbiota and specifically by microbial-derived short-chain fatty acids (SCFAs). (Direct, High; PMID: 26030851)
• SCFAs have been shown to dampen inflammatory responses by inactivating NF-κB and downregulating proinflammatory cytokines like TNF-α and IL-6. (Derived, Low; PMID: 27231050, PMID: 41774188)

Predictions

• Exogenous butyrate supplementation in high-fat diet-fed mice will lead to a significant reduction in hippocampal NF-κB p65 phosphorylation and lower mRNA levels of Tnf and Il6. (Indirect, Low; PMID: 41859191, PMID: 41846933)
• Butyrate treatment will result in increased global H3 acetylation and specifically hyperacetylation at the promoters of negative regulators of TLR4 signaling (e.g., Socs1) in isolated microglia. (Indirect, Low; PMID: 24226773, PMID: 41773902)
• Mice treated with butyrate will demonstrate reduced immobility time in the forced swim test compared to untreated obese controls, indicating an alleviation of depressive-like phenotypes. (Indirect, Low; PMID: 41859191)

Study design

An in vivo study using C57BL/6J mice divided into four groups: standard diet (control), high-fat diet (obese), high-fat diet + butyrate, and high-fat diet + butyrate + HDAC inhibitor antagonist. Primary outcomes will include behavioral testing (Forced Swim Test, Tail Suspension Test), intestinal permeability assays (FITC-dextran), and neuroinflammatory profiling (microglial morphology analysis, hippocampal cytokine quantification via RT-qPCR and Western Blot). Chromatin immunoprecipitation (ChIP) will be performed to assess histone H3 acetylation levels at the TLR4 and NF-κB promoter regions in flow-sorted CD11b+CD45lo microglia. (Derived, Medium; PMID: 26030851, PMID: 41823868, PMID: 41859191)

Confounders & controls

• Use of germ-free mice as a negative control to confirm the microbiota-dependent nature of SCFA-mediated effects. (Derived, Low; PMID: 26030851)
• Controlling for dietary intake and body weight to ensure that the neuroprotective effects of butyrate are independent of weight loss itself. (Direct, High; PMID: 41762317)
• Standardizing sample collection times to account for circadian rhythm influences on gut microbiota and behavior. (Direct, High; PMID: 41762381)

Risks/limitations

• Microglial cell lines or primary cultures may not fully recapitulate the complexity of in vivo neuro-immune signaling networks. (Derived, Low; PMID: 41762317)
• High concentrations of butyrate may have non-physiological effects or trigger different pathways compared to gut-derived concentrations. (Indirect, Low; PMID: 41835120)

Falsification criteria

• The hypothesis is falsified if butyrate supplementation fails to reduce depressive behaviors in obese mice despite significant hippocampal HDAC inhibition. (Indirect, Low; PMID: 41859191)
• The hypothesis is falsified if neuroinflammatory markers are reduced in GPR43/Ffar2 knockout mice following butyrate treatment, suggesting a receptor-independent mechanism. (Derived, Medium; PMID: 26030851)

Unverified Citations

The following sources failed to support their assigned claims after 3 verification rounds designed to ensure only high-confidence, relevant references are retained:

• PMID: 23828891 — The hypothesis is falsified if neuroinflammatory markers are reduced in GPR43/Ffar2 knockout mice following butyrate tre...
  Failed: disease,conclusion — The paper studies colonic Treg cells (cTregs) and intestinal inflammation, not neuroinflammation or neuroinflammatory markers.